These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 34484246)

  • 1. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
    Vella G; Guelfi S; Bergers G
    Front Immunol; 2021; 12():736670. PubMed ID: 34484246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.
    Jones E; Gallimore A; Ager A
    Methods Mol Biol; 2018; 1845():99-118. PubMed ID: 30141010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High endothelial venules in cancer: Regulation, function, and therapeutic implication.
    Vella G; Hua Y; Bergers G
    Cancer Cell; 2023 Mar; 41(3):527-545. PubMed ID: 36827979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High endothelial venules (HEVs) in immunity, inflammation and cancer.
    Blanchard L; Girard JP
    Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1
    Hua Y; Vella G; Rambow F; Allen E; Antoranz Martinez A; Duhamel M; Takeda A; Jalkanen S; Junius S; Smeets A; Nittner D; Dimmeler S; Hehlgans T; Liston A; Bosisio FM; Floris G; Laoui D; Hollmén M; Lambrechts D; Merchiers P; Marine JC; Schlenner S; Bergers G
    Cancer Cell; 2022 Dec; 40(12):1600-1618.e10. PubMed ID: 36423635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding high endothelial venules: Lessons for cancer immunology.
    Ager A; May MJ
    Oncoimmunology; 2015 Jun; 4(6):e1008791. PubMed ID: 26155419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Cellular Requirements for the Assembly of Tertiary Lymphoid Structures.
    Mueller CG; Nayar S; Campos J; Barone F
    Adv Exp Med Biol; 2018; 1060():55-72. PubMed ID: 30155622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.
    Sawada J; Hiraoka N; Qi R; Jiang L; Fournier-Goss AE; Yoshida M; Kawashima H; Komatsu M
    Cancer Immunol Res; 2022 Apr; 10(4):468-481. PubMed ID: 35201289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Generation of hPSC-Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities.
    Wang X; Li X; Zhao J; Li Y; Shin SR; Ligresti G; Ng AHM; Bromberg JS; Church G; Lemos DR; Abdi R
    Adv Mater; 2024 Apr; 36(15):e2308760. PubMed ID: 38306610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
    Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
    Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.
    Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW
    Front Immunol; 2021; 12():675538. PubMed ID: 34054863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and Vascular Components of Tertiary Lymphoid Structures.
    Mueller CG; Nayar S; Gardner D; Barone F
    Methods Mol Biol; 2018; 1845():17-30. PubMed ID: 30141005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases.
    Kobayashi M; Fukuda M; Nakayama J
    Biol Pharm Bull; 2009 May; 32(5):774-9. PubMed ID: 19420741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling.
    Kanda H; Tanaka T; Matsumoto M; Umemoto E; Ebisuno Y; Kinoshita M; Noda M; Kannagi R; Hirata T; Murai T; Fukuda M; Miyasaka M
    Int Immunol; 2004 Sep; 16(9):1265-74. PubMed ID: 15249540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis.
    Bai Z; Cai L; Umemoto E; Takeda A; Tohya K; Komai Y; Veeraveedu PT; Hata E; Sugiura Y; Kubo A; Suematsu M; Hayasaka H; Okudaira S; Aoki J; Tanaka T; Albers HM; Ovaa H; Miyasaka M
    J Immunol; 2013 Mar; 190(5):2036-48. PubMed ID: 23365076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.
    Menzel L; Höpken UE; Rehm A
    Front Immunol; 2020; 11():591741. PubMed ID: 33343570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Effect of Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated Gastric Carcinomas Measured by Digital Image Analysis.
    Cho YJ; Hwang I; Park S; Lee S; Kang SY; Kim MJ; Ahn S; Kim KM
    Lab Invest; 2024 Jul; 104(7):102071. PubMed ID: 38677591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.